Context Therapeutics

Philadelphia, United States

Context Therapeutics is a clinical-stage biopharmaceutical company.

$100.0M raised

May 2024

Post-IPO Equity

Biotechnology Health Care

Top Investors

Blue Owl Great Point Partners Blackstone Group Avidity Partners Ally Bridge Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Context Therapeutics

How much funding has Context Therapeutics raised?

Context Therapeutics has raised $100.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2024.

Who are Context Therapeutics's investors?

Context Therapeutics's investors include Blue Owl, Great Point Partners, Blackstone Group, Avidity Partners, Ally Bridge Group.

Where is Context Therapeutics headquartered?

Context Therapeutics is headquartered in Philadelphia, United States.

What does Context Therapeutics do?

Context Therapeutics is a clinical-stage biopharmaceutical company.

What stage is Context Therapeutics at?

Context Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 2, 2024.

MLA

"Context Therapeutics — Funding & Investors." VCBacked, May 2, 2024, https://www.vcbacked.co/company/context-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Context Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/context-therapeutics

Wikipedia (cite web)

{{cite web |title=Context Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/context-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 2, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K